CCM
Camber Capital Management Portfolio holdings
AUM
$718M
1-Year Est. Return
4.23%
This Fund
S&P 500
1 Year Est. Return
-4.23%
AUM
$1.6B
AUM Growth
-$954M
(-37%)
Holding
38
Top Buys
| 1 | +$73M | |
| 2 | +$38.5M | |
| 3 | +$19.8M | |
| 4 |
Cigna
CI
|
+$16.4M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$3.53M |
Top Sells
| 1 | +$220M | |
| 2 | +$142M | |
| 3 | +$86.6M | |
| 4 |
GSK
GSK
|
+$84.5M |
| 5 |
Ascendis Pharma
ASND
|
+$70.1M |
Sector Composition
| 1 | Healthcare | 100% |
| 2 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Structure Therapeutics
GPCR
$6.16B
| $5.19M | 0.18% |
300,000
|
|
||
27
OraSure Technologies
OSUR
$200M
| $3.03M | 0.11% |
900,000
-3,350,000
|
|
||
28
Genmab
GMAB
$20.5B
| $979K | 0.03% |
50,000
|
|
||
29
Herbalife
HLF
$1.75B
| – | – |
-3,000,000
|
|
||
30
Jazz Pharmaceuticals
JAZZ
$9.96B
| – | – |
-1,150,000
|
|
||
31
Medtronic
MDT
$129B
| – | – |
-2,750,000
|
|
||
32
Medpace
MEDP
$16.7B
| – | – |
-125,000
|
|
||
|
MRUS
33
DELISTED
Merus
MRUS
| – | – |
-250,000
|
|
||
34
State Street SPDR S&P 500 ETF Trust
SPY
$711B
| – | – |
0
|
|
||
35
State Street SPDR S&P Biotech ETF
XBI
$8.49B
| – | – |
0
|
|
||
|
BKDT
36
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
| – | – |
-250,000
|
|
||
37
Alkermes
ALKS
$5.76B
| – | – |
-1,500,000
|
|
||
|
38
GSK
GSK
$102B
| – | – |
-2,500,000
|
|